Real-world Clinical Effectiveness and Patient Insight Associated With Adding Sodium Glucose Co-transporter 2 Inhibitor to Gliclazide Modified Release
Clinical trial NCT06708091 · COMPLETED
Trial details
- NCT number
- NCT06708091
- Sponsor
- Servier Affaires Médicales
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-15
- Primary completion
- 2024-05-31
- Enrollment
- 537
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.